Search In this Thesis
   Search In this Thesis  
العنوان
Effect of transcutaneous electrical nerve stimulation on interstitial cystitis /
الناشر
Norhan Mostafa Mahmoud ,
المؤلف
Norhan Mostafa Mahmoud
هيئة الاعداد
باحث / Norhan Mostafa Mahmoud
مشرف / Zakaria Mowafy Emam Mowafy
مشرف / Ahmed Abdellatef Moharam
مشرف / Ashraf Hassan Mohammed
تاريخ النشر
2016
عدد الصفحات
129 P. :
اللغة
الإنجليزية
الدرجة
ماجستير
التخصص
العلاج الطبيعي والرياضة والعلاج وإعادة التأهيل
تاريخ الإجازة
10/4/2017
مكان الإجازة
جامعة القاهرة - علاج طبيعي - Physical Therapy for Surgery
الفهرس
Only 14 pages are availabe for public view

from 150

from 150

Abstract

To determine the effect of transcutaneous electrical nerve stimulation (TENS) on interstitial cystitis/painful bladder syndrome. Measurement of the visual analogue scale (VAS) and estimation of the clomipramine medicament intake (CMI). Thirty male patients who had interstitial cystitis/painful bladder syndrome were participated in the study. They recruited from the urology department of Cairo university hospitals, their ages were ranged from 30 to 50 years, they were randomly divided into 2 equal groups in number, one study group (A) and a control one (B). All patients in the 2 groups (A) and (B) received the same traditional physical therapy and home exercises in the form of pelvic floor exercises. Also all patients received the same medical care and medications. group (A): received the transcutaneous electrical nerve stimulation in addition to the traditional physical therapy and medical care for 4 months. Control group (B): received only the traditional physical therapy and medical care for 4 months, each treatment session was conducted for 15 minutes, two electrodes were positioned suprapubically, while the other two electrodes were applied under the lower back (T10-L1) with the patient in comfortable supine hook-lying position with abducted hips. Results showed a highly significant reduction in VAS and CMI at the end of the treatment program in groups (A) only. So TENS was effective in improving the interstitial cystitis/painful bladder syndrome as manifested by the highly significant reduction in VAS and CMI